Nuveen LLC Takes $502,000 Position in National Research Corporation $NRC

Key Points

• Nuveen LLC invested $502,000 in National Research Corporation, acquiring 39,235 shares during the first quarter, representing 0.17% ownership of the company.
• National Research recently reported earnings of $0.28 per share and announced a quarterly dividend of $0.12, yielding 3.2% annually.
• Institutional investors currently own 47.26% of National Research, indicating significant interest from the investment community.

Nuveen LLC purchased a new position in shares of National Research Corporation (NASDAQ:NRC - Free Report) during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 39,235 shares of the company's stock, valued at approximately $502,000. Nuveen LLC owned approximately 0.17% of National Research as of its most recent filing with the Securities and Exchange Commission.

Several other large investors also recently bought and sold shares of NRC. Azzad Asset Management Inc. ADV purchased a new position in National Research in the 1st quarter valued at about $426,000. Envestnet Asset Management Inc. increased its holdings in National Research by 23.1% during the 1st quarter. Envestnet Asset Management Inc. now owns 89,985 shares of the company's stock worth $1,152,000 after purchasing an additional 16,868 shares during the last quarter. Ameriprise Financial Inc. raised its position in shares of National Research by 92.9% in the 4th quarter. Ameriprise Financial Inc. now owns 34,552 shares of the company's stock valued at $610,000 after purchasing an additional 16,643 shares in the last quarter. GAMMA Investing LLC increased its stake in shares of National Research by 45,978.8% in the first quarter. GAMMA Investing LLC now owns 15,206 shares of the company's stock worth $195,000 after buying an additional 15,173 shares during the last quarter. Finally, M&T Bank Corp acquired a new stake in National Research in the first quarter valued at $164,000. Institutional investors and hedge funds own 47.26% of the company's stock.

National Research Stock Down 1.5%

NASDAQ NRC traded down $0.25 during trading hours on Wednesday, reaching $15.89. 82,433 shares of the company traded hands, compared to its average volume of 90,585. The company has a 50 day moving average of $15.00 and a two-hundred day moving average of $14.25. The stock has a market capitalization of $366.42 million, a PE ratio of 20.91 and a beta of 0.47. National Research Corporation has a 12 month low of $9.76 and a 12 month high of $22.99. The company has a current ratio of 0.70, a quick ratio of 0.70 and a debt-to-equity ratio of 3.61.

National Research (NASDAQ:NRC - Get Free Report) last issued its earnings results on Monday, July 28th. The company reported $0.28 earnings per share (EPS) for the quarter. The business had revenue of $34.04 million for the quarter. National Research had a net margin of 12.78% and a return on equity of 83.52%.

National Research Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date is Friday, September 26th. National Research's payout ratio is 63.16%.

National Research Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.